#commercializing - Techseriesinsight

June 9, 2025
PRNewswire
Biotechnology

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

Dynavax Technologies Corporation (Nasdaq: DVAX) (“Dynavax” or the “Company”), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today issued the following statement reiterating to stockholders its recommendation to vote “FOR”...

May 5, 2025
PRNewswire
Blockchain Technology

Atlas Data Storage Announces Initial Close of Seed Financing

Atlas Data Storage, Inc., a technology company building end-to-end DNA data storage, announced today the close of a $155 million seed financing and the acquisition of technology assets from Twist Bioscience....

May 1, 2025
PRNewswire
Biotechnology

Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits

Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, today announced the results of the Hepatitis B Perceptions and Insights Survey conducted by The Harris Poll, which...